Richard Groenendijk

Richard Groenendijk is a seasoned finance professional with extensive experience in the biotech and capital markets sectors. Currently serving as Managing Partner and CFO at Remora Biotech since May 2018, Richard Groenendijk plays a pivotal role in supporting growth for the venture builder specializing in immunotherapy. Additionally, Richard Groenendijk is a board member at MKB Biopharma. Prior experience includes a tenure at CONTINENTAL CAPITAL MARKETS S.A. as Senior Advisor for Russia and Manager of Emerging Markets, along with a position as Head of CIS/Balkans and Senior Partner at Kepler Cheuvreux. Richard Groenendijk began a career at Rabobank where responsibilities spanned global foreign exchange sales, trading, and client management. Richard Groenendijk holds a degree from Amsterdam University of Applied Sciences.